Pharmaceutical / Drug Definition :
Selectively inhibits norepinephrine and serotonin reuptake at presynaptic neurons in brain; also possesses moderate anticholinergic properties.
FDA Label Requirements and Exceptions
Clomipramine Hydrochloride
FDA Import Information
Clomipramine Hydrochloride
FDA Detentions
Clomipramine Hydrochloride (Clomipramine Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Clomipramine Hydrochloride (Clomipramine Hydrochloride Suppliers)
- Processors Clomipramine Hydrochloride
- Repackers Clomipramine Hydrochloride
- Relabelers Clomipramine Hydrochloride
- Exporters Clomipramine Hydrochloride
- Importers Clomipramine Hydrochloride
For more information about Clomipramine Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
